{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:16:26Z","timestamp":1740125786858,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K24 AA027483"],"award-info":[{"award-number":["K24 AA027483"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s11606-022-07865-y","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T16:06:11Z","timestamp":1668701171000},"page":"1638-1646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5394-609X","authenticated-orcid":false,"given":"Jarratt D.","family":"Pytell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetanjali","family":"Chander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish P.","family":"Thakrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Michelle","family":"Ogunwole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma E.","family":"McGinty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"issue":"14","key":"7865_CR1","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJMp1917360","volume":"382","author":"ND Volkow","year":"2020","unstructured":"Volkow ND. Stigma and the toll of addiction. N Engl J Med. 2020;382(14):1289-1290. https:\/\/doi.org\/10.1056\/NEJMp1917360","journal-title":"N Engl J Med."},{"issue":"12","key":"7865_CR2","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1111\/add.15069","volume":"115","author":"BL Perry","year":"2020","unstructured":"Perry BL, Pescosolido BA, Krendl AC. The unique nature of public stigma toward non-medical prescription opioid use and dependence: a national study. Addiction. 2020;115(12):2317-2326. https:\/\/doi.org\/10.1111\/add.15069","journal-title":"Addiction."},{"issue":"11","key":"7865_CR3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1176\/appi.ajp.2010.09121743","volume":"167","author":"BA Pescosolido","year":"2010","unstructured":"Pescosolido BA, Martin JK, Long JS, Medina TR, Phelan JC, Link BG. \u201cA disease like any other\u201d? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am J Psychiatry. 2010;167(11):1321-1330. https:\/\/doi.org\/10.1176\/appi.ajp.2010.09121743","journal-title":"Am J Psychiatry."},{"issue":"4","key":"7865_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344-350. https:\/\/doi.org\/10.1097\/YCO.0000000000000717","journal-title":"Curr Opin Psychiatry."},{"issue":"5","key":"7865_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1176\/appi.ps.201600056","volume":"68","author":"A Kennedy-Hendricks","year":"2017","unstructured":"Kennedy-Hendricks A, Barry CL, Gollust SE, Ensminger ME, Chisolm MS, McGinty EE. Social stigma toward persons with prescription opioid use disorder: associations with public support for punitive and public health-oriented policies. Psychiatr Serv Wash DC. 2017;68(5):462-469. https:\/\/doi.org\/10.1176\/appi.ps.201600056","journal-title":"Psychiatr Serv Wash DC."},{"issue":"7","key":"7865_CR6","doi-asserted-by":"publisher","first-page":"e2222149","DOI":"10.1001\/jamanetworkopen.2022.22149","volume":"5","author":"A Harocopos","year":"2022","unstructured":"Harocopos A, Gibson BE, Saha N, et al. First 2 months of operation at first publicly recognized overdose prevention centers in US. JAMA Netw Open. 2022;5(7):e2222149. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.22149","journal-title":"JAMA Netw Open."},{"key":"7865_CR7","doi-asserted-by":"publisher","first-page":"102769","DOI":"10.1016\/j.drugpo.2020.102769","volume":"80","author":"A Ivsins","year":"2020","unstructured":"Ivsins A, Boyd J, Beletsky L, McNeil R. Tackling the overdose crisis: the role of safe supply. Int J Drug Policy. 2020;80:102769. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102769","journal-title":"Int J Drug Policy."},{"key":"7865_CR8","unstructured":"U.S. Department of Health and Human Services (HHS), Office of the Surgeon General. Facing Addiction in America: The Surgeon General\u2019s Spotlight on Opioids. HHS; 2018. https:\/\/addiction.surgeongeneral.gov\/sites\/default\/files\/Spotlight-on-Opioids_09192018.pdf"},{"key":"7865_CR9","unstructured":"American Society of Addiction Medicine. Public policy statement: definition of addiction 2019. Published September 15, 2019. Accessed October 2, 2020. https:\/\/www.asam.org\/Quality-Science\/definition-of-addiction"},{"issue":"4","key":"7865_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMra1511480","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363-371. https:\/\/doi.org\/10.1056\/NEJMra1511480","journal-title":"N Engl J Med."},{"issue":"7","key":"7865_CR11","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/add.15333","volume":"116","author":"JF Kelly","year":"2021","unstructured":"Kelly JF, Greene MC, Abry A. A US national randomized study to guide how best to reduce stigma when describing drug-related impairment in practice and policy. Addiction. 2021;116(7):1757-1767. https:\/\/doi.org\/10.1111\/add.15333","journal-title":"Addiction."},{"issue":"6","key":"7865_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.cpr.2013.06.002","volume":"33","author":"EP Kvaale","year":"2013","unstructured":"Kvaale EP, Haslam N, Gottdiener WH. The \u2018Side Effects\u2019 of medicalization: a meta-analytic review of how biogenetic explanations affect stigma. Clin Psychol Rev. 2013;33(6):782-794. https:\/\/doi.org\/10.1016\/j.cpr.2013.06.002","journal-title":"Clin Psychol Rev."},{"issue":"4","key":"7865_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/002214650504600401","volume":"46","author":"JC Phelan","year":"2005","unstructured":"Phelan JC. Geneticization of deviant behavior and consequences for stigma: the case of mental illness. J Health Soc Behav. 2005;46(4):307-322. https:\/\/doi.org\/10.1177\/002214650504600401","journal-title":"J Health Soc Behav."},{"issue":"3","key":"7865_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11606-021-06925-z","volume":"37","author":"JD Pytell","year":"2022","unstructured":"Pytell JD, Sklar MD, Carrese J, Rastegar DA, Gunn C, Chander G. \u201cI\u2019m a survivor\u201d: perceptions of chronic disease and survivorship among individuals in long-term remission from opioid use disorder. J Gen Intern Med. 2022;37(3):593-600. https:\/\/doi.org\/10.1007\/s11606-021-06925-z","journal-title":"J Gen Intern Med."},{"issue":"25","key":"7865_CR15","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMra1712502","volume":"379","author":"CL Shapiro","year":"2018","unstructured":"Shapiro CL. Cancer survivorship. N Engl J Med. 2018;379(25):2438-2450. https:\/\/doi.org\/10.1056\/NEJMra1712502","journal-title":"N Engl J Med."},{"issue":"4","key":"7865_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s11013-016-9496-5","volume":"40","author":"J Netherland","year":"2016","unstructured":"Netherland J, Hansen HB. The war on drugs that wasn\u2019t: wasted whiteness, \u201cdirty doctors,\u201d and race in media coverage of prescription opioid misuse. Cult Med Psychiatry. 2016;40(4):664-686. https:\/\/doi.org\/10.1007\/s11013-016-9496-5","journal-title":"Cult Med Psychiatry."},{"issue":"2","key":"7865_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/maq.12449","volume":"33","author":"S Mendoza","year":"2019","unstructured":"Mendoza S, Rivera AS, Hansen HB. Re-racialization of addiction and the redistribution of blame in the white opioid epidemic. Med Anthropol Q. 2019;33(2):242-262. https:\/\/doi.org\/10.1111\/maq.12449","journal-title":"Med Anthropol Q."},{"issue":"12","key":"7865_CR18","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2105\/AJPH.2016.303483","volume":"106","author":"H Hansen","year":"2016","unstructured":"Hansen H, Netherland J. Is the prescription opioid epidemic a white problem? Am J Public Health. 2016;106(12):2127-2129. https:\/\/doi.org\/10.2105\/AJPH.2016.303483","journal-title":"Am J Public Health."},{"issue":"6","key":"7865_CR19","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1377\/hlthaff.2020.02261","volume":"40","author":"B Andraka-Christou","year":"2021","unstructured":"Andraka-Christou B. Addressing racial and ethnic disparities in the use of medications for opioid use disorder. Health Aff (Millwood). 2021;40(6):920-927. https:\/\/doi.org\/10.1377\/hlthaff.2020.02261","journal-title":"Health Aff (Millwood)."},{"issue":"9","key":"7865_CR20","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","volume":"76","author":"PA Lagisetty","year":"2019","unstructured":"Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine treatment divide by race\/ethnicity and payment. JAMA Psychiatry. 2019;76(9):979-981. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.0876","journal-title":"JAMA Psychiatry."},{"key":"7865_CR21","unstructured":"Alexander M, West C. The New Jim Crow: Mass Incarceration in the Age of Colorblindness. Revised edition. New Press; 2012."},{"issue":"4","key":"7865_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/08897077.2018.1449166","volume":"39","author":"BD Stein","year":"2018","unstructured":"Stein BD, Dick AW, Sorbero M, et al. A population-based examination of trends and disparities in medication treatment for opioid use disorders among medicaid enrollees. Subst Abuse. 2018;39(4):419-425. https:\/\/doi.org\/10.1080\/08897077.2018.1449166","journal-title":"Subst Abuse."},{"key":"7865_CR23","doi-asserted-by":"publisher","unstructured":"Hansen H, Roberts SK. Two tiers of biomedicalization: methadone, buprenorphine, and the racial politics of addiction treatment. In: Netherland J, ed. Advances in Medical Sociology. Emerald Group Publishing Limited; 2012:79-102. https:\/\/doi.org\/10.1108\/S1057-6290(2012)0000014008","DOI":"10.1108\/S1057-6290(2012)0000014008"},{"key":"7865_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drugalcdep.2016.10.020","volume":"169","author":"M Kulesza","year":"2016","unstructured":"Kulesza M, Matsuda M, Ramirez JJ, Werntz AJ, Teachman BA, Lindgren KP. Towards greater understanding of addiction stigma: intersectionality with race\/ethnicity and gender. Drug Alcohol Depend. 2016;169:85-91. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.10.020","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"7865_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1467-9280.2009.02282.x","volume":"20","author":"JH Wirth","year":"2009","unstructured":"Wirth JH, Bodenhausen GV. The role of gender in mental-illness stigma: a national experiment. Psychol Sci. 2009;20(2):169-173. https:\/\/doi.org\/10.1111\/j.1467-9280.2009.02282.x","journal-title":"Psychol Sci."},{"issue":"Suppl 2","key":"7865_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/SART.S23328","volume":"9","author":"M Terplan","year":"2015","unstructured":"Terplan M, Kennedy-Hendricks A, Chisolm MS. Prenatal substance use: exploring assumptions of maternal unfitness. Subst Abuse Res Treat. 2015;9(Suppl 2):1-4. https:\/\/doi.org\/10.4137\/SART.S23328","journal-title":"Subst Abuse Res Treat."},{"issue":"1","key":"7865_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.mcna.2021.08.007","volume":"106","author":"MTH Harris","year":"2022","unstructured":"Harris MTH, Laks J, Stahl N, Bagley SM, Saia K, Wechsberg WM. Gender dynamics in substance use and treatment: a women\u2019s focused approach. Med Clin North Am. 2022;106(1):219-234. https:\/\/doi.org\/10.1016\/j.mcna.2021.08.007","journal-title":"Med Clin North Am."},{"key":"7865_CR28","doi-asserted-by":"crossref","unstructured":"McGinty EE. Portraying mental illness and drug addiction as treatable health conditions: effects of a randomized experiment on stigma and discrimination. Soc Sci. Published online 2015:13.","DOI":"10.1016\/j.socscimed.2014.12.010"},{"key":"7865_CR29","doi-asserted-by":"publisher","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95(May). https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","DOI":"10.1016\/j.jbi.2019.103208"},{"issue":"2","key":"7865_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform."},{"issue":"4","key":"7865_CR31","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3758\/s13428-014-0532-5","volume":"47","author":"DS Ma","year":"2015","unstructured":"Ma DS, Correll J, Wittenbrink B. The Chicago face database: a free stimulus set of faces and norming data. Behav Res Methods. 2015;47(4):1122-1135. https:\/\/doi.org\/10.3758\/s13428-014-0532-5","journal-title":"Behav Res Methods."},{"key":"7865_CR32","unstructured":"ASAM Definition of Addiction. Accessed January 21, 2021. https:\/\/www.asam.org\/Quality-Science\/definition-of-addiction"},{"issue":"10","key":"7865_CR33","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41386-020-00950-y","volume":"46","author":"M Heilig","year":"2021","unstructured":"Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2021;46(10):1715-1723. https:\/\/doi.org\/10.1038\/s41386-020-00950-y","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol."},{"issue":"3","key":"7865_CR34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1360-0443.2010.03194.x","volume":"106","author":"C Lopez-Quintero","year":"2011","unstructured":"Lopez-Quintero C, Hasin DS, de Los Cobos JP, et al. Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the national epidemiologic survey on alcohol and related conditions. Addict Abingdon Engl. 2011;106(3):657-669. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03194.x","journal-title":"Addict Abingdon Engl."},{"issue":"Suppl 12","key":"7865_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2105\/ajph.64.12_suppl.38","volume":"64","author":"LN Robins","year":"1974","unstructured":"Robins LN, Davis DH, Nurco DN. How permanent was Vietnam drug addiction? Am J Public Health. 1974;64 Suppl 12:38-43. https:\/\/doi.org\/10.2105\/ajph.64.12_suppl.38","journal-title":"Am J Public Health."},{"key":"7865_CR36","doi-asserted-by":"publisher","unstructured":"Hagman BT, Falk D, Litten R, Koob GF. Defining recovery from alcohol use disorder: development of an NIAAA research definition. Am J Psychiatry. Published online April 12, 2022:appi.ajp.21090963. https:\/\/doi.org\/10.1176\/appi.ajp.21090963","DOI":"10.1176\/appi.ajp.21090963"},{"key":"7865_CR37","unstructured":"Leeper T. margins: Marginal Effects for Model Objects. Published online 2021."},{"key":"7865_CR38","unstructured":"R Core Team. R: a language and environment for statistical computing. Published online 2021."},{"issue":"2","key":"7865_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1037\/h0045357","volume":"21","author":"CR Rogers","year":"1957","unstructured":"Rogers CR. The necessary and sufficient conditions of therapeutic personality change. J Consult Psychol. 1957;21(2):95-103. https:\/\/doi.org\/10.1037\/h0045357","journal-title":"J Consult Psychol."},{"key":"7865_CR40","unstructured":"Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. Guilford Press; 2013."},{"issue":"1","key":"7865_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/ADM.0000000000000832","volume":"16","author":"DM Schiff","year":"2022","unstructured":"Schiff DM, Stoltman JJK, Nielsen TC, et al. Assessing stigma towards substance use in pregnancy: a randomized study testing the impact of stigmatizing language and type of opioid use on attitudes toward mothers with opioid use disorder. J Addict Med. 2022;16(1):77-83. https:\/\/doi.org\/10.1097\/ADM.0000000000000832","journal-title":"J Addict Med."},{"issue":"S2","key":"7865_CR42","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.2105\/AJPH.2021.306645","volume":"112","author":"AK Lie","year":"2022","unstructured":"Lie AK, Hansen H, Herzberg D, et al. The harms of constructing addiction as a chronic, relapsing brain disease. Am J Public Health. 2022;112(S2):S104-S108. https:\/\/doi.org\/10.2105\/AJPH.2021.306645","journal-title":"Am J Public Health."},{"key":"7865_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ypmed.2018.02.026","volume":"111","author":"EE McGinty","year":"2018","unstructured":"McGinty EE, Barry CL, Stone EM, et al. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 2018;111:73-77. https:\/\/doi.org\/10.1016\/j.ypmed.2018.02.026","journal-title":"Prev Med."},{"issue":"2","key":"7865_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.7326\/M19-3975","volume":"173","author":"EE McGinty","year":"2020","unstructured":"McGinty EE, Stone EM, Kennedy-Hendricks A, Bachhuber MA, Barry CL. Medication for opioid use disorder: a national survey of primary care physicians. Ann Intern Med. 2020;173(2):160-162. https:\/\/doi.org\/10.7326\/M19-3975","journal-title":"Ann Intern Med."},{"issue":"6","key":"7865_CR45","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","volume":"34","author":"SL Calcaterra","year":"2019","unstructured":"Calcaterra SL, Bach P, Chadi A, et al. Methadone matters: what the United States can learn from the global effort to treat opioid addiction. J Gen Intern Med. 2019;34(6):1039-1042. https:\/\/doi.org\/10.1007\/s11606-018-4801-3","journal-title":"J Gen Intern Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-022-07865-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T01:04:09Z","timestamp":1700183049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-022-07865-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["7865"],"URL":"https:\/\/doi.org\/10.1007\/s11606-022-07865-y","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"type":"print","value":"0884-8734"},{"type":"electronic","value":"1525-1497"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}